BioCryst Pharma (BCRX) PT Raised to $21 at Barclays

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/29/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

August 6, 2021 5:25 AM EDT
Get Alerts BCRX Hot Sheet
Price: $9.82 -0.51%

Rating Summary:
    17 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Barclays analyst Gena Wang raised the price target on BioCryst Pharma (NASDAQ: BCRX) to $21.00 (from $20.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change